ERBB2 and malignant colon neoplasm: The HER2-overexpressing colon cancer cell lines DLD1 and COLO201 but also the non-overexpressing NSCLC cell line NCI H2030 showed between 15 and 30% of HER2-positive cells albeit with lower expression levels, similar to MCF7 cell line (Fig. 6B, C).